Hostname: page-component-7c8c6479df-5xszh Total loading time: 0 Render date: 2024-03-27T20:33:31.730Z Has data issue: false hasContentIssue false

Low dietary intake of β-carotene, α-tocopherol and ascorbic acid is associated with increased inflammatory and oxidative stress status in a Swedish cohort

Published online by Cambridge University Press:  15 December 2008

Johanna Helmersson
Affiliation:
Department of Research and Development, County Council of Gävleborg/Uppsala University, Gävle Hospital, SE-801 87Gävle, Sweden Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism/Geriatrics, Faculty of Medicine, Uppsala University, Uppsala Science Park, SE-751 85Uppsala, Sweden
Johan Ärnlöv
Affiliation:
Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism/Geriatrics, Faculty of Medicine, Uppsala University, Uppsala Science Park, SE-751 85Uppsala, Sweden
Anders Larsson
Affiliation:
Department of Medical Sciences, Clinical Chemistry, Uppsala University Hospital, SE-751 85Uppsala, Sweden
Samar Basu*
Affiliation:
Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism/Geriatrics, Faculty of Medicine, Uppsala University, Uppsala Science Park, SE-751 85Uppsala, Sweden Center of Excellence-Inflammation, Uppsala University Hospital, Uppsala, Sweden
*
*Corresponding author: Dr Samar Basu, fax +46 18 611 79 76, email samar.basu@pubcare.uu.se
Rights & Permissions [Opens in a new window]

Abstract

Fruit and vegetable consumption has been associated with a reduced risk of several diseases including CVD. A part of these effects seen could be linked to anti-inflammatory and antioxidative effects, although this has not been thoroughly investigated. The present study was designed to investigate the effects of the dietary intake of β-carotene, α-tocopherol and ascorbic acid on in vivo biomarkers of inflammation (PGF, high-sensitive C-reactive protein (hsCRP) and IL-6 formation) and oxidative stress (F2-isoprostane formation), the two important factors associated with accelerated atherosclerosis. The dietary intake of 704 participants in the Uppsala Longitudinal Study of Adult Men (ULSAM) at age 70 years was registered and inflammatory and oxidative stress biomarkers were quantified 7 years later. The registered dietary intakes of ascorbic acid and α-tocopherol were negatively associated linearly and in quartiles with both PGF, hsCRP, IL-6 and F2-isoprostanes, where ascorbic acid intake generally was more strongly associated. Dietary intake of β-carotene was only significantly negatively associated with F2-isoprostanes. In conclusion, the present study is the first to suggest that the intake of food rich in antioxidants is associated with reduced cyclo-oxygenase- and cytokine-mediated inflammation and oxidative stress at 7 years of follow-up. These associations could be linked to the beneficial effects of fruit and vegetables observed on CVD.

Type
Full Papers
Copyright
Copyright © The Authors 2008

Fruit and vegetable consumption has been associated with a reduced risk of several diseases including CVD(Reference Bazzano, He and Ogden1). Studies have suggested that chronic low-grade inflammation and free radicals in excess may play a role in the development of atherosclerotic plaques subsequently leading to diseases in the cardiovascular system(Reference Ross2, Reference Steinberg, Parthasarathy and Carew3). Antioxidants, usually found in fruits and vegetables, may be beneficial by reducing the levels of inflammation and free radicals in vitro (Reference Ames, Shigenaga and Hagen4) but the role of antioxidants in vivo in atherosclerosis and CVD is still largely unknown and under constant debate. Epidemiological studies have shown that humans with either a high dietary intake of or a high blood concentration of α-tocopherol, β-carotene and ascorbic acid have a lower risk of developing CVD(Reference Asplund5, Reference Clarke and Armitage6). On the other hand, large placebo-controlled intervention studies have not shown any beneficial cardiovascular effects of α-tocopherol, β-carotene or ascorbic acid supplementation(Reference Clarke and Armitage6Reference Eidelman, Hollar and Hebert8). From these contradictory data it may be concluded that the regulation of antioxidants, inflammation and free radicals in atherosclerosis is a complex process and yet not fully understood. One approach to acquire more knowledge of the role of antioxidants in atherogenesis may be to study the impact of dietary vitamin intake and to relate these vitamins to the levels of inflammation and free radicals in vivo.

Inflammatory processes can be studied by the quantification of cyclo-oxygenase (COX)-induced or cytokine-mediated products(Reference Helmersson, Vessby and Larsson9). Prostaglandins and thromboxanes are derived from arachidonic acid; COX catalyses their formation endogenously. These prostanoids are important mediators of vasoconstrictive and inflammatory processes(Reference Bergström10, Reference Vane11). PGF is one of the major prostaglandins formed at sites of inflammation(Reference Willoughby12, Reference Mutschler, Eriksson and Wikström13) and its formation in vivo is preferably quantified by the measurement of 15-keto-dihydro-PGF(Reference Samuelsson14), which is a major metabolite of PGF in plasma. 15-Keto-dihydro-PGF has been shown to be a potent indicator of PGF formation and COX-mediated inflammatory processes in vivo (Reference Basu15, Reference Basu and Eriksson16).

F2-isoprostanes, structural isomers of PGF, are formed during free radical-catalysed (non-enzymic) peroxidation of arachidonic acid(Reference Morrow, Hill and Burk17). 8-Iso-PGF, a major F2-isoprostane, is a reliable indicator of oxidative stress in vivo. Enhanced formation of F2-isoprostanes has been associated with coronary artery disease(Reference Shishehbor, Zhang and Medina18) and several risk factors for atherosclerosis including diabetes, obesity and hypercholesterolaemia, as reviewed earlier(Reference Basu and Helmersson19).

In a recent study we showed that high levels of the antioxidant Se in serum were associated with reduced formation of the inflammatory mediator PGF and the oxidative stress indicator F2-isoprostanes after a long follow-up(Reference Helmersson, Ärnlöv and Vessby20). The aim of the present study was to study the relationships of registered dietary intake of other antioxidants, namely ascorbic acid, α-tocopherol and β-carotene, with levels of inflammation (PGF, high-sensitive C-reactive protein (CRP) and IL-6 formation) and free radicals (F2-isoprostane formation) in a 7-year follow-up study.

Materials and methods

Study population

The present study is based on 704 study participants from the re-investigations of the Uppsala Longitudinal Study of Adult Men (ULSAM) in 1990–3 and 1997–2001. This population-based cohort originally started in 1970–3, when all men born 1920–4 and living in Uppsala (Sweden) were invited to participate in a health screening at age 50 years as previously described(Reference Hedstrand21). The cohort was re-investigated after 20 and 27 years. Out of the re-investigated men, 704 were eligible for evaluation of inflammation and oxidative stress at age 77 years and had dietary data from the re-investigation at age 70 years. The Ethics Committee at Uppsala University approved the study and all participants gave informed consent.

Dietary assessment of vitamins

The intake of dietary ascorbic acid, α-tocopherol and β-carotene was estimated with the use of a 7 d pre-coded food record as part of the investigation at age 70 years. The validity and design of the dietary assessment has previously been described in detail(Reference Smedman, Gustafsson and Berglund22). In brief, a dietitian instructed all subjects to record their dietary intake using a 7 d pre-coded food diary. Daily intakes of the antioxidants were calculated using a computerised program (MATs; Rudans Lättdata, Västerås, Sweden) and the Swedish National Food Administration database.

Biochemical analysis of indicators of inflammation and oxidative stress

Urine was collected over 24 h. Blood samples were drawn in heparinised tubes in the morning after an overnight fast and plasma was separated. Both urine and plasma were stored at − 70°C until analysis. Free 8-iso-PGF in urine was analysed by a RIA as previously described by Basu(Reference Basu23). The intra-assay CV was 14·5 % at low and 12·2 % at high concentrations. Urinary 15-keto-dihydro-PGF was analysed by a RIA developed as previously described by Basu(Reference Basu15). The intra-assay CV was 12·2 % at low and 14·0 % at high concentrations. Levels of 8-iso-PGF and 15-keto-dihydro-PGF were corrected for urinary creatinine analysed as described previously(Reference Helmersson and Basu24). IL-6 was analysed by a high-sensitivity ELISA kit (IL-6 HS; R&D Systems, Minneapolis, MN, USA). The total CV of the method was 7 % and inter-assay CV was 5 %. High-sensitive CRP measurements were performed by latex-enhanced reagent (Dade Behring, Deerfield, IL, USA) with the use of a Behring BN ProSpec analyser (Dade Behring). Intra-assay CV of the high-sensitive CRP method was 1·4 % at both 1·23 and 5·49 mg/l. One high-sensitive CRP outlier (116 mg/l) was excluded from the statistical analysis.

Statistical analysis

Variables with skewed distribution, according to the Shapiro–Wilk test (W < 0·95), were log-transformed to reach normal distribution. Associations between dietary vitamins and eicosanoids and cytokines, respectively, were tested in linear regression models with the respective vitamin as the dependent variable and eicosanoids and cytokines as independent variables. BMI as a continuous variable, diabetes (plasma glucose ≥ 7·0 mmol/l or anti-diabetic medication), hyperlipidaemia (serum cholesterol >6·5 mmol/l or TAG >2·3 mmol/l or lipid-lowering medication), hypertension (office blood pressure >140/90 mmHg or anti-hypertensive medication) and smoking at baseline were considered as potential confounders based on associations earlier reported from this cohort or from other studies(Reference Helmersson, Vessby and Larsson9, Reference Basu and Helmersson19, Reference Basu25). Dietary vitamins were entered into the models as continuous variables and in quartiles. P values < 0·05 were regarded as statistically significant. Calculations were performed with Stata 8.2 (StataCorp LP, College Station, TX, USA).

Results

Baseline characteristics of the study population and dietary vitamin intake

In the cohort of men aged 70 years, 9 % had diabetes mellitus, 29 % hypertension, 36 % hyperlipidaemia and 16 % were active smokers. Mean BMI was 26·3 (sd 3·27) kg/m2. The mean dietary intake of ascorbic acid was 54·2 (sd 35·4) mg/d. Quartile 1 corresponds to 4·73–29·8 mg/d; 2 to 29·9–46·5 mg/d; 3 to 46·6–68·1 mg/d; 4 to 68·2–285 mg/d of ascorbic acid intake. The mean dietary intake of α-tocopherol was 5·80 (sd 2·03) mg/d. Quartile 1 corresponds to 1·62–4·33 mg/d; 2 to 4·34–5·40 mg/d; 3 to 5·41–6·66 mg/d; 4 to 6·68–34·9 mg/d of α-tocopherol intake. The mean dietary intake of β-carotene was 1·74 (sd 1·41) mg/d. Quartile 1 corresponds to 0·08–0·79 mg/d; 2 to 0·80–1·38 mg/d; 3 to 1·39–2·20 mg/d; 4 to 2·21–11·9 mg/d of β-carotene intake.

Dietary vitamins and PGF (indicator of cyclo-oxygenase-mediated inflammation)

The registered intake of dietary ascorbic acid was negatively associated with PGF formation linearly (regression coefficient (b) − 46·9; P < 0·05) and in quartiles (Fig. 1) at follow-up. The linear association did not substantially change when adjusted for potential confounders at baseline, but the association between the highest and lowest quartile of ascorbic acid intake was attenuated (P = 0·085).

Fig. 1 PGF formation (pmol/mmol creatinine) in quartiles of dietary intake of ascorbic acid (a), α-tocopherol (b) and β-carotene (c), where quartile 1 is low intake. PGF formation is estimated as urinary 15-keto-dihydro-PGF. Note that the y axis is cut at 200 pmol/mmol. Values are means, with standard errors represented by vertical bars. *Mean value is significantly different from that for quartile 1 (P < 0·05). †Mean value is marginally significantly different from that for quartile 1 (P = 0·06). For ascorbic acid, P for trend = 0·007; for α-tocopherol P for trend = 0·06; for β-carotene P for trend = 0·21.

Intake of α-tocopherol was negatively associated with PGF formation at a borderline significance level linearly (b = − 35·1; P = 0·06) and in quartiles (Fig. 1). These results were substantially attenuated when adjusted for potential confounders (P = 0·15).

Intake of β-carotene in the diet was not significantly associated with PGF formation (Fig. 1).

Dietary vitamins and high-sensitive C-reactive protein (indicator of cytokine-related inflammation)

The registered intakes of dietary ascorbic acid and α-tocopherol were negatively associated with CRP linearly (b = − 0·14, P < 0·001 and b = − 0·15, P < 0·001, respectively) and in quartiles (Fig. 2) at follow-up. The results did not substantially change when adjusted for potential confounders at baseline.

Fig. 2 C-reactive protein (mg/l) in quartiles of dietary intake of ascorbic acid (a), α-tocopherol (b) and β-carotene (c), where quartile 1 is low intake. Values are means, with standard errors represented by vertical bars. Mean value is significantly different from that for quartile 1: *P < 0·05, **P < 0·01, ***P < 0·001. For ascorbic acid, P for trend < 0·001; for α-tocopherol P for trend < 0·001; for β-carotene P for trend = 0·14.

The estimated intake of β-carotene was not linearly associated with high-sensitive CRP (data not shown), but quartiles with high intake (quartiles 4 and 2) of β-carotene were associated with lower levels of high-sensitive CRP compared with the quartile with the lowest intake of β-carotene (Fig. 2). However, adjusting for potential confounders at baseline removed these associations.

Dietary vitamins and interleukin-6 (indicator of cytokine-related inflammation)

Intakes of dietary ascorbic acid and α-tocopherol were linearly negatively associated with IL-6 at follow-up (b = − 0·06, P < 0·05 and b = − 0·07, P < 0·01, respectively). The quartile with the estimated highest intake of ascorbic acid and α-tocopherol had the lowest levels of IL-6 compared with the quartile with the lowest intake (Fig. 3). The results were attenuated when adjusted for potential confounders: P = 0·066 (ascorbic acid) and P < 0·05 (α-tocopherol).

Fig. 3 IL-6 (ng/l) in quartiles of dietary intake of ascorbic acid (a), α-tocopherol (b) and β-carotene (c), where quartile 1 is low intake. Values are means, with standard errors represented by vertical bars. Mean value is significantly different from that for quartile 1: *P < 0·05, **P < 0·01. For ascorbic acid, P for trend = 0·009; for α-tocopherol P for trend = 0·002; for β-carotene P for trend = 0·18.

The estimated intake of β-carotene was not linearly associated with IL-6 (data not shown), but quartiles with high intake (quartiles 3 and 2) of β-carotene were associated with lower levels of IL-6 compared with the quartile with the lowest intake of β-carotene (Fig. 3). However, adjusting for potential confounders at baseline removed these associations.

Dietary vitamins and F2-isoprostanes (indicator of oxidative stress)

Intakes of dietary ascorbic acid, α-tocopherol and β-carotene were linearly negatively associated with F2-isoprostane formation at follow-up (b = − 41·3, P < 0·05; b = − 34·1, P < 0·05; b = − 48·0, P < 0·05, respectively). The quartile with the estimated highest intake of ascorbic acid as well as the highest intake of β-carotene had the lowest levels of F2-isoprostane formation compared with the quartile with the lowest intake (Fig. 4). The results were unchanged (ascorbic acid, α-tocopherol) or even stronger (β-carotene) when adjusted for potential confounders.

Fig. 4 F2-isoprostane formation (pmol/mmol creatinine) in quartiles of dietary intake of ascorbic acid (a), α-tocopherol (b) and β-carotene (c), where quartile 1 is low intake. F2-formation is estimated as urinary 8-iso-PGF. Note that the y axis is cut at 100 pmol/mmol. Values are means, with standard errors represented by vertical bars. *Mean value is significantly different from that for quartile 1 (P < 0·05). †Mean value is marginally significantly different from that for quartile 1 (P = 0·05). For ascorbic acid, P for trend = 0·01; for α-tocopherol P for trend = 0·13; for β-carotene P for trend = 0·03.

Discussion

The novel finding in the present study is that the registered dietary intake of ascorbic acid and α-tocopherol was inversely associated with PGF formation, which may be interpreted as the higher the intake of food containing ascorbic acid and α-tocopherol the lower the level of COX-mediated inflammation. The association with α-tocopherol was, however, somewhat weaker, especially when adjusting for potential confounders. Studies evaluating the relationship between ascorbic acid and α-tocopherol, respectively, and PGF are very sparse and this may be due to the earlier difficulties in quantification and estimation of PGF formation. Serum α-tocopherol and PGF formation was not associated cross-sectionally in this cohort as previously reported(Reference Helmersson, Vessby and Larsson9). On the other hand, there was a positive correlation found between serum γ-tocopherol and PGF formation(Reference Helmersson, Vessby and Larsson26), although γ-tocopherol was not studied in the present study. An earlier published study showed that supplementation with α-tocopherol at relatively low doses (200 mg α-tocopherol/d) for 2 weeks or gradually increased doses (16–400 IU (10·7–266·7 mg) α-tocopherol/d) for 4 weeks did not change the level of PGF formation(Reference Smedman, Vessby and Basu27, Reference Basu, Lee and Dunster28).

A higher intake of food containing ascorbic acid, α-tocopherol and to some extent also β-carotene was also associated with lower levels of CRP and IL-6, indicating a lower level of cytokine-mediated inflammation related to higher vitamin intake. These associations are supported by a number of cross-sectional studies showing an inverse correlation between ascorbic acid in serum, blood, plasma and diet, and CRP levels(Reference Szeto, Kwok and Benzie29Reference Wannamethee, Lowe and Rumley32). The relationship between α-tocopherol and CRP seems to be far more complicated in the literature. Plasma α-tocopherol has been shown to be inversely correlated with CRP levels in one study(Reference McMillan, Talwar and Sattar33) but serum α-tocopherol and CRP levels were actually positively correlated in an earlier study published from this present cohort(Reference Helmersson, Vessby and Larsson9). Some studies have shown a lack of association between α-tocopherol in plasma and serum and CRP(Reference Szeto, Kwok and Benzie29, Reference Chang, Chen and Ke34). However, to our knowledge no study has evaluated the dietary intake of α-tocopherol and CRP or IL-6. Intake of ascorbic acid via supplements has revealed conflicting results; some studies have shown a reduced level of CRP(Reference Block, Jensen and Dietrich35) while others have failed to show CRP-lowering effects of ascorbic acid supplementation(Reference Upritchard, Sutherland and Mann36, Reference Tahir, Foley and Pate37). The intake of α-tocopherol supplements has been shown to lead to reduced levels of CRP in one study(Reference Upritchard, Sutherland and Mann36) while a combination of α-tocopherol and ascorbic acid did not alter CRP(Reference Tahir, Foley and Pate37, Reference Bruunsgaard, Poulsen and Pedersen38) or IL-6(Reference Bruunsgaard, Poulsen and Pedersen38). A number of earlier published studies of β-carotene estimated in blood, serum and plasma and CRP confirm the weak inverse association between dietary β-carotene and CRP seen in the present study(Reference van Herpen-Broekmans, Klopping-Ketelaars and Bots30, Reference Ford, Liu and Mannino31, Reference McMillan, Talwar and Sattar33, Reference Chang, Chen and Ke34, Reference Erlinger, Guallar and Miller39). There is also a study that shows an inverse association between β-carotene and IL-6(Reference Hu, Reuben and Crimmins40), a correlation that we could not find in the present study.

A higher intake of food containing ascorbic acid, α-tocopherol and β-carotene was related to reduced levels of F2-isoprostanes. This would indicate that the higher the intake of these vitamins in the diet the less oxidative stress in vivo. We have previously reported an inverse association between α-tocopherol in serum and F2-isoprostane formation(Reference Helmersson, Vessby and Larsson9). A supplementation study with vegetable soup containing ascorbic acid showed that F2-isoprostane formation could be decreased by intake of this soup, but a control group was missing in this study(Reference Sanchez-Moreno, Cano and de Ancos41). There are a number of supplementation studies concerning α-tocopherol and ascorbic acid which evaluated the effects on F2-isoprostane formation as reviewed earlier(Reference Basu and Helmersson19). In brief, F2-isoprostane formation in healthy humans is generally not affected by α-tocopherol or ascorbic acid supplementation. In conditions where F2-isoprostane formation is increased, such as type 2 diabetes, homocysteinaemia and hypercholesterolaemia, α-tocopherol supplementation may be beneficial in reducing the F2-isoprostane level if given in appropriate doses and longer duration(Reference Roberts, Oates and Linton42). Ascorbic acid supplementation may decrease the elevated F2-isoprostane formation in smokers(Reference Dietrich, Block and Hudes43, Reference Reilly, Delanty and Lawson44). Supplementation with β-carotene alone did not alter F2-isoprostane formation(Reference Mayne, Walter and Cartmel45).

To summarise, a high intake of food rich in ascorbic acid seems to show the most obvious association with reduced levels of all investigated indicators of inflammation (PGF, CRP, IL-6) and oxidative stress (F2-isoprostanes) in the present study. A high intake of food rich in α-tocopherol was also related to reduced levels of PGF, CRP, IL-6 and F2-isoprostanes, but the associations were weaker and in some case were affected by confounding factors. On the other hand, a high intake of β-carotene from the diet was only related to reduced F2-isoprostane formation. It may be that these antioxidants by their different properties and mechanisms affect inflammation and oxidative stress differently. Ascorbic acid is a water-soluble chain-breaking antioxidant, tocopherols and tocotrienols (vitamin E) are lipid-soluble chain-breaking antioxidants and carotenoids (including β-carotene) are lipid-soluble antioxidants that effectively scavenge singlet oxygen. The earlier published inverse associations between Se (which has antioxidative properties mainly through the glutathione peroxidase system), and PGF and F2-isoprostanes, but not CRP, IL-6 or serum amyloid A protein, may support this theory(Reference Helmersson, Ärnlöv and Vessby20). It may also be true that the associations found in the present study merely reflect an association between a large intake of fruits and vegetables in general and a reduced level of inflammation and oxidative stress and that this association may be mediated through an unknown factor or mechanism not studied here.

A recommended daily intake of vitamins according to the Swedish National Food Administration today is 75 mg ascorbic acid, 10 mg α-tocopherol and 10·8 mg β-carotene. It may be noted that only those in the highest quartile of the respective vitamin intake achieved these health recommendations. A general well-known problem of food registrations is the constant and sometimes selective underestimation of the dietary intake. However, a possible underestimation of vitamin intake would rather tend to diminish the observed associations in the present study.

It may also be discussed whether these studied vitamins have any direct anti-inflammatory effect or if the reduced levels of inflammation seen related to a high intake of vitamins are secondary to their well-documented antioxidative effect. There are several mechanisms described in the literature by which free radicals (oxidative stress) may be linked to the inflammatory pathway. A recent study showed that intravenous infusion of F2-isoprostanes, specifically 8-iso-PGF, in rabbits causes an increase in COX-catalysed PGF formation(Reference Basu46). Phospholipase A2, which hydrolyses phospholipids in the membrane allowing arachidonic acid and subsequently prostaglandins to form, can be activated by H2O2 (reactive oxygen species)(Reference Chan, Yurko and Fishman47, Reference Rao, Runge and Alexander48). Reactive oxygen species might also up-regulate phospholipase A2 by the IκB kinase (IKK)/NF-κB pathway(Reference Senftleben and Karin49). NF-κB is a nuclear transcription factor regulating cytokines (IL-6), cell-adhesion molecules, acute-phase proteins (CRP), phospholipase A2 and COX-2 in a complex series of biochemical processes.

The present study was carried out in a fairly large age-, sex- and ethnicity-matched population, which is an advantage when studying inflammation and free radicals, as these levels may vary due to the above-mentioned factors(Reference Basu and Helmersson19). On the other hand, the results may have limited generalisability to other age and ethnic groups and women. Further, the studied subgroup of the cohort may be healthier than the general population. The studied subgroup may also be healthier than the whole unselected cohort at age 70 years, as can be noted from slightly higher percentages of diabetes mellitus (15 %), smokers (21 %) and hypertension prevalence (32 %) in the whole unselected cohort at age 70 years (compared with the subgroup followed up with biomarkers). Hyperlipidaemia prevalence and BMI were the same in the whole cohort at age 70 years as in the subgroup followed up 7 years later. However, the healthy cohort effect would probably bias the results towards the null hypothesis and not lead to overestimation of the associations. Although the study has a longitudinal design with a follow-up of 7 years, it cannot be excluded that the associations found also would be found in a cross-sectional analysis. A limitation in the study is that we did not have data on vitamin supplements. However, it can be speculated that general Swedish men of age 70 years in 1990–3 did not take vitamin supplements to a large extent.

The dietary intake of vitamins was unfortunately not validated at follow-up. The Swedish National Food Administration concluded based on two food surveys (in 1989 and 1997) that the intake of tocopherols in the diet did not change, while the intake of ascorbic acid in the diet increased slightly and the intake of carotenes decreased slightly in men aged 18–74 years during the years 1989–97(Reference Becker and Pearson50). Changes in vitamin intake in the elderly are expected to be smaller. However, it is very unlikely that changes in nutrient intake during the years of follow-up would bias the results towards a type 1 error; rather, the associations would be more difficult to detect. Serum concentrations of α-tocopherol at baseline and after 7 years of follow-up correlated well (R 0·54; P < 0·0001), which also supports the assumption of small changes in consumption during follow-up.

In conclusion, the present study is the first to report that a registered large intake of a diet rich in several vitamins is associated with reduced inflammation, mediated by both COX and cytokines, and reduced oxidative stress 7 years later. Whether these effects seen are a consequence of a general effect of a healthy diet or a more direct consequence of intake of these specific vitamins can, however, not be concluded from the results of the present study. Yet, these anti-inflammatory and antioxidative effects of a large intake of food rich in vitamins may be linked to the beneficial effects of fruits and vegetables seen on CVD and cancer.

Acknowledgements

We thank Eva Sejby deceased, Barbro Simu and Siv Tengblad for technical assistance. J. H., J. Ä., B. V. and S. B. designed the study. J. H. and J. Ä. performed the statistical analysis. A. L. performed the analyses of inflammatory cytokines. J. H. and S. B. performed the eicosanoid analyses. All authors assisted in interpretation and presentation of the results. J. H. drafted the manuscript with S. B. and J. Ä. contributing.

None of the authors had any conflict of interest related to the present study.

References

1Bazzano, LA, He, J, Ogden, LG, et al. (2002) Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nutr 76, 9399.Google Scholar
2Ross, R (1999) Atherosclerosis – an inflammatory disease. N Engl J Med 340, 115126.Google Scholar
3Steinberg, D, Parthasarathy, S, Carew, TE, et al. (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320, 915924.Google Scholar
4Ames, BN, Shigenaga, MK & Hagen, TM (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 90, 79157922.Google Scholar
5Asplund, K (2002) Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J Intern Med 251, 372392.Google Scholar
6Clarke, R & Armitage, J (2002) Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials. Cardiovasc Drugs Ther 16, 411415.Google Scholar
7Vivekananthan, DP, Penn, MS, Sapp, SK, et al. (2003) Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361, 20172023.Google Scholar
8Eidelman, RS, Hollar, D, Hebert, PR, et al. (2004) Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med 164, 15521556.Google Scholar
9Helmersson, J, Vessby, B, Larsson, A, et al. (2004) Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 109, 17291734.Google Scholar
10Bergström, S (1967) Prostaglandins: members of a new hormonal system. These physiologically very potent compounds of ubiquitous occurrence are formed from essential fatty acids. Science 157, 382391.Google Scholar
11Vane, JR (1976) Prostaglandins as mediators of inflammation. Adv Prostaglandin Thromboxane Res 2, 791801.Google Scholar
12Willoughby, DA (1975) Heberden Oration, 1974. Human arthritis applied to animal models. Towards a better therapy. Ann Rheum Dis 34, 471478.Google Scholar
13Mutschler, DK, Eriksson, MB, Wikström, BG, et al. (2003) Microdialysis-evaluated myocardial cyclooxygenase-mediated inflammation and early circulatory depression in porcine endotoxemia. Crit Care Med 31, 17801785.Google Scholar
14Samuelsson, B (1973) Quantitative aspects on prostaglandin synthesis in man. Adv Biosci 9, 714.Google Scholar
15Basu, S (1998) Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2α: an index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 58, 347352.Google Scholar
16Basu, S & Eriksson, M (1998) Oxidative injury and survival during endotoxemia. FEBS Lett 438, 159160.Google Scholar
17Morrow, JD, Hill, KE, Burk, RF, et al. (1990) A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A 87, 93839387.Google Scholar
18Shishehbor, MH, Zhang, R, Medina, H, et al. (2006) Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease. Free Radic Biol Med 41, 16781683.Google Scholar
19Basu, S & Helmersson, J (2005) Factors regulating isoprostane formation in vivo. Antioxid Redox Signal 7, 221235.Google Scholar
20Helmersson, J, Ärnlöv, J, Vessby, B, et al. (2005) Serum selenium predicts levels of F2-isoprostanes and prostaglandin F2α in a 27 year follow-up study of Swedish men. Free Radic Res 39, 763770.Google Scholar
21Hedstrand, H (1975) A study of middle-aged men with particular reference to risk factors for cardiovascular disease. Ups J Med Sci Suppl 19, 161.Google Scholar
22Smedman, AE, Gustafsson, IB, Berglund, LG, et al. (1999) Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am J Clin Nutr 69, 2229.Google Scholar
23Basu, S (1998) Radioimmunoassay of 8-iso-prostaglandin F2α: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 58, 319325.Google Scholar
24Helmersson, J & Basu, S (1999) F2-isoprostane excretion rate and diurnal variation in human urine. Prostaglandins Leukot Essent Fatty Acids 61, 203205.Google Scholar
25Basu, S (2007) Novel cyclooxygenase-catalyzed bioactive prostaglandin F2α from physiology to new principles in inflammation. Med Res Rev 27, 435468.Google Scholar
26Helmersson, J, Vessby, B, Larsson, A, et al. (2005) Cyclooxygenase-mediated prostaglandin F2α is decreased in an elderly population treated with low-dose aspirin. Prostaglandins Leukot Essent Fatty Acids 72, 227233.Google Scholar
27Smedman, A, Vessby, B & Basu, S (2004) Isomer-specific effects of conjugated linoleic acid on lipid peroxidation in humans: regulation by α-tocopherol and cyclo-oxygenase-2 inhibitor. Clin Sci (Lond) 106, 6773.Google Scholar
28Basu, S, Lee, R, Dunster, C, et al. (2004) Lipid peroxidation biomarker changes in humans in response to increasing doses of α-tocopherol. Abstract. In Proceedings of the New York Academy of Science: Vitamin E and Health, p. P11. New York: New York Academy of Science.Google Scholar
29Szeto, YT, Kwok, TC & Benzie, IF (2004) Effects of a long-term vegetarian diet on biomarkers of antioxidant status and cardiovascular disease risk. Nutrition 20, 863866.Google Scholar
30van Herpen-Broekmans, WM, Klopping-Ketelaars, IA, Bots, ML, et al. (2004) Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. Eur J Epidemiol 19, 915921.Google Scholar
31Ford, ES, Liu, S, Mannino, DM, et al. (2003) C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. Eur J Clin Nutr 57, 11571163.Google Scholar
32Wannamethee, SG, Lowe, GD, Rumley, A, et al. (2006) Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr 83, 567574, quiz 726–727.Google Scholar
33McMillan, DC, Talwar, D, Sattar, N, et al. (2002) The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours. Clin Nutr 21, 161164.Google Scholar
34Chang, CY, Chen, JY, Ke, D, et al. (2005) Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits. Nutrition 21, 987993.Google Scholar
35Block, G, Jensen, C, Dietrich, M, et al. (2004) Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation. J Am Coll Nutr 23, 141147.Google Scholar
36Upritchard, JE, Sutherland, WH & Mann, JI (2000) Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 23, 733738.Google Scholar
37Tahir, M, Foley, B, Pate, G, et al. (2005) Impact of vitamin E and C supplementation on serum adhesion molecules in chronic degenerative aortic stenosis: a randomized controlled trial. Am Heart J 150, 302306.Google Scholar
38Bruunsgaard, H, Poulsen, HE, Pedersen, BK, et al. (2003) Long-term combined supplementations with α-tocopherol and vitamin C have no detectable anti-inflammatory effects in healthy men. J Nutr 133, 11701173.Google Scholar
39Erlinger, TP, Guallar, E, Miller, ER III, et al. (2001) Relationship between systemic markers of inflammation and serum α-carotene levels. Arch Intern Med 161, 19031908.Google Scholar
40Hu, P, Reuben, DB, Crimmins, EM, et al. (2004) The effects of serum β-carotene concentration and burden of inflammation on all-cause mortality risk in high-functioning older persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 59, 849854.Google Scholar
41Sanchez-Moreno, C, Cano, MP, de Ancos, B, et al. (2004) Consumption of high-pressurized vegetable soup increases plasma vitamin C and decreases oxidative stress and inflammatory biomarkers in healthy humans. J Nutr 134, 30213025.Google Scholar
42Roberts, L J II, Oates, JA, Linton, MF, et al. (2007) The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med 43, 13881393.Google Scholar
43Dietrich, M, Block, G, Hudes, M, et al. (2002) Antioxidant supplementation decreases lipid peroxidation biomarker F(2)-isoprostanes in plasma of smokers. Cancer Epidemiol Biomarkers Prev 11, 713.Google Scholar
44Reilly, M, Delanty, N, Lawson, JA, et al. (1996) Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94, 1925.Google Scholar
45Mayne, ST, Walter, M, Cartmel, B, et al. (2004) Supplemental β-carotene, smoking, and urinary F2-isoprostane excretion in patients with prior early stage head and neck cancer. Nutr Cancer 49, 16.Google Scholar
46Basu, S (2006) F2-isoprostane induced prostaglandin formation in the rabbit. Free Radic Res 40, 273277.Google Scholar
47Chan, PH, Yurko, M & Fishman, RA (1982) Phospholipid degradation and cellular edema induced by free radicals in brain cortical slices. J Neurochem 38, 525531.Google Scholar
48Rao, GN, Runge, MS & Alexander, RW (1995) Hydrogen peroxide activation of cytosolic phospholipase A2 in vascular smooth muscle cells. Biochim Biophys Acta 1265, 6772.Google Scholar
49Senftleben, U & Karin, M (2002) The IKK/NF-κB pathway. Crit Care Med 30, S18S26.Google Scholar
50Becker, W & Pearson, M (2002) Kostvanor och Näringsintag i Sverige 1997–1998. Metod och Resultatanalys (Food Habits and Nutrients in Sweden 1997–1998. Method and Results Analysis). Uppsala, Sweden: Swedish National Food Administration.Google Scholar
Figure 0

Fig. 1 PGF formation (pmol/mmol creatinine) in quartiles of dietary intake of ascorbic acid (a), α-tocopherol (b) and β-carotene (c), where quartile 1 is low intake. PGF formation is estimated as urinary 15-keto-dihydro-PGF. Note that the y axis is cut at 200 pmol/mmol. Values are means, with standard errors represented by vertical bars. *Mean value is significantly different from that for quartile 1 (P < 0·05). †Mean value is marginally significantly different from that for quartile 1 (P = 0·06). For ascorbic acid, P for trend = 0·007; for α-tocopherol P for trend = 0·06; for β-carotene P for trend = 0·21.

Figure 1

Fig. 2 C-reactive protein (mg/l) in quartiles of dietary intake of ascorbic acid (a), α-tocopherol (b) and β-carotene (c), where quartile 1 is low intake. Values are means, with standard errors represented by vertical bars. Mean value is significantly different from that for quartile 1: *P < 0·05, **P < 0·01, ***P < 0·001. For ascorbic acid, P for trend < 0·001; for α-tocopherol P for trend < 0·001; for β-carotene P for trend = 0·14.

Figure 2

Fig. 3 IL-6 (ng/l) in quartiles of dietary intake of ascorbic acid (a), α-tocopherol (b) and β-carotene (c), where quartile 1 is low intake. Values are means, with standard errors represented by vertical bars. Mean value is significantly different from that for quartile 1: *P < 0·05, **P < 0·01. For ascorbic acid, P for trend = 0·009; for α-tocopherol P for trend = 0·002; for β-carotene P for trend = 0·18.

Figure 3

Fig. 4 F2-isoprostane formation (pmol/mmol creatinine) in quartiles of dietary intake of ascorbic acid (a), α-tocopherol (b) and β-carotene (c), where quartile 1 is low intake. F2-formation is estimated as urinary 8-iso-PGF. Note that the y axis is cut at 100 pmol/mmol. Values are means, with standard errors represented by vertical bars. *Mean value is significantly different from that for quartile 1 (P < 0·05). †Mean value is marginally significantly different from that for quartile 1 (P = 0·05). For ascorbic acid, P for trend = 0·01; for α-tocopherol P for trend = 0·13; for β-carotene P for trend = 0·03.